BCAX Latest Press Releases

-- November 4, 2026 --

Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:30 AM

-- November 2, 2026 --

Bicara Therapeutics to Report Third Quarter 2026 Financial Results and Business Updates on November 9, 2026, at 8:30 AM ET Globe Newswire 8:30 AM

-- October 5, 2026 --

Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:30 AM

-- September 3, 2026 --

Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:30 AM

-- August 14, 2026 --

Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:30 AM

-- August 11, 2026 --

Bicara Therapeutics Reports Second Quarter 2026 Progress and Announces Strategic Leadership Transitions Marking Next Era of Execution and Growth Globe Newswire 7:30 AM

-- August 4, 2026 --

Bicara Therapeutics to Report Second Quarter 2026 Financial Results and Business Updates on August 11, 2026, at 8:30 AM ET Globe Newswire 8:30 AM

-- July 28, 2026 --

Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors Globe Newswire 8:30 AM

-- July 2, 2026 --

Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes